Mitigating methane emissions, and testing AI-developed medication
[ad_1]
A Palo Alto–primarily based startup needs to start releasing iron particles into the exhaust stream of a transport vessel crossing the ocean inside the subsequent 18 months.
Blue Dot Change hopes to find out whether or not the particles will speed up the destruction of methane, some of the highly effective greenhouse gasses within the environment.
It’s amongst a handful of small industrial ventures which can be itching to check whether or not releasing comparable particles might curb local weather change. However little is thought about different results of releasing the particles, together with probably harmful ones. Learn the total story.
—James Temple
AI is dreaming up medication that nobody has ever seen. Now we’ve acquired to see in the event that they work.
At 82 years previous, with an aggressive type of blood most cancers that six programs of chemotherapy had did not get rid of, “Paul” seemed to be out of choices. His docs enrolled him in a trial testing a brand new know-how that pairs particular person sufferers with the medication they want.
Two years on, Paul’s most cancers was gone. The know-how was developed by Exscientia, which is without doubt one of the tons of of startups exploring the usage of machine studying in prescribed drugs, with the shared imaginative and prescient of utilizing AI to make drug discovery sooner and cheaper.
AI is already altering how medication are being made. But it’s nonetheless early days for AI drug discovery— and there are a whole lot of corporations making claims they’ll’t again up. Learn the total story.
—Will Douglas Heaven
[ad_2]
No Comment! Be the first one.